188 related articles for article (PubMed ID: 17586722)
1. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase.
Gori JL; Podetz-Pedersen K; Swanson D; Karlen AD; Gunther R; Somia NV; McIvor RS
J Pharmacol Exp Ther; 2007 Sep; 322(3):989-97. PubMed ID: 17586722
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate.
James RI; May C; Vagt MD; Studebaker R; McIvor RS
Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
May C; James RI; Gunther R; McIvor RS
J Pharmacol Exp Ther; 1996 Sep; 278(3):1444-51. PubMed ID: 8819532
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrow.
Belur LR; Boelk-Galvan D; Diers MD; McIvor RS; Zimmerman CL
Cancer Res; 2001 Feb; 61(4):1522-6. PubMed ID: 11245460
[TBL] [Abstract][Full Text] [Related]
5. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
Vinh DB; McIvor RS
J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
[TBL] [Abstract][Full Text] [Related]
7. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
Havenga M; Valerio D; Hoogerbrugge P; Es H
Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
[TBL] [Abstract][Full Text] [Related]
8. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
9. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
[TBL] [Abstract][Full Text] [Related]
11. Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.
Zhao SC; Li MX; Banerjee D; Schweitzer BI; Mineishi S; Gilboa E; Bertino JR
Cancer Gene Ther; 1994 Mar; 1(1):27-33. PubMed ID: 7621235
[TBL] [Abstract][Full Text] [Related]
12. [Double-mutant dihydrofolate reductase gene transfection into bone marrow cells protects mice from chemotherapy].
Gao HD; Lu P; Lu Y; Pang K; Xu HM; Wang SB; Chen JQ; Zhao SC
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):583-5. PubMed ID: 17236551
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
McIvor RS
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.
Mineishi S; Nakahara S; Takebe N; Banerjee D; Zhao SC; Bertino JR
Gene Ther; 1997 Jun; 4(6):570-6. PubMed ID: 9231073
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated bycounterflow elutriation.
James R; May C; Diers M; Wagner J; McIvor R
Bone Marrow Transplant; 1999 Oct; 24(8):815-21. PubMed ID: 10516690
[TBL] [Abstract][Full Text] [Related]
16. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vectors containing a variant dihydrofolate reductase gene for drug protection and in vivo selection of hematopoietic cells.
Allay JA; Galipeau J; Blakley RL; Sorrentino BP
Stem Cells; 1998; 16 Suppl 1():223-33. PubMed ID: 11012166
[TBL] [Abstract][Full Text] [Related]
18. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil.
Capiaux GM; Budak-Alpdogan T; Takebe N; Mayer-Kuckuk P; Banerjee D; Maley F; Bertino JR
Hum Gene Ther; 2003 Mar; 14(5):435-46. PubMed ID: 12691609
[TBL] [Abstract][Full Text] [Related]
19. Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity.
May C; Gunther R; McIvor RS
Blood; 1995 Sep; 86(6):2439-48. PubMed ID: 7662992
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]